HP Health Solutions Germany GmbH, operating under the brand GNA Biosolutions, is at the forefront of innovation in the Molecular Diagnostics sector. Founded in 2010 and headquartered in Germany, the company is pioneering advancements in Biotechnology and Health Care.
The company's slogan, "Breaking the limits of molecular diagnostics," aptly encapsulates its mission to push boundaries and enhance diagnostic capabilities. This focus highlights their commitment to addressing complex health challenges with cutting-edge solutions.
In terms of financial backing, GNA Biosolutions secured a significant $13.50M Series C investment on 01 August 2019. This funding round attracted prominent investors such as UVC Partners, Robert Bosch Venture Capital, GreyBird Ventures, Mey Capital Matrix, Occident, and b2venture, showcasing strong confidence in the company's potential.